Skip to main content
. 2019 Jul 19;80(6):831–836. doi: 10.1002/ddr.21566

Table 1.

Characteristics of the individuals involved in the study

IBD patients N = 49
Age (mean ± SD) 44.48 ± 14.34
Sex (%M) 69%
Treatment and duration
Drug free 24.50%
5‐ASA 51% (12–144 months)
Anti‐TNF 24.5% (3–48 months)
Activity of the disease
Remission 26.5%
Active 73.5%
Non‐IBD controls N = 18
Age (mean ± SD) 47.11 ± 17.47
Sex (%M) 44%

Note. Socio demographic and clinical characteristics of individuals involved in the study.